GAL and breast carcinoma: In addition, they showed that tumor-derived Gal-1 promotes an immunosuppressive breast cancer microenvironment by increasing the frequency of CD4+CD25+ Foxp3+ Treg cells within the tumor, draining lymph nodes, spleen, and lung metastases [62].